These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Coagulation factors and components of the fibrinolytic system in lymph and blood in dogs. Leandoer L; Bergentz SE; Nilsson IM Thromb Diath Haemorrh; 1968 Mar; 19(1):129-35. PubMed ID: 5652223 [No Abstract] [Full Text] [Related]
4. Blood clotting and fibrinolytic studies in patients with muscular dystrophy. Bond TP; Guest MM Tex Rep Biol Med; 1964 Dec; 22():Suppl 1:886-9. PubMed ID: 5830976 [No Abstract] [Full Text] [Related]
5. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"]. Daver J; Albugues MJ; du Pasquier JP; Ricoeur M Pathol Biol (Paris); 1970; 18(11):687-94. PubMed ID: 4247466 [No Abstract] [Full Text] [Related]
6. [Determination of the components of fibrinolytic system]. Slobozhankina IK Lab Delo; 1973; 11():662-4. PubMed ID: 4132568 [No Abstract] [Full Text] [Related]
7. [Research on a new fibrinolytic agent extracted from human placenta (Thromboclase)]. Ponari O; Dallavalle L; Dettori AG; Gallese R Therapie; 1968; 23(4):737-50. PubMed ID: 4245312 [No Abstract] [Full Text] [Related]
8. [On the physiology of blood coagulation and fibrinolysis as the basic principles in the clinical use of anticoagulants, thrombolytics and inhibitors of fibrinolysis]. Van de Loo J Rev Colomb Obstet Ginecol; 1967; 18(5):321-6. PubMed ID: 5612568 [No Abstract] [Full Text] [Related]
9. [Micromethods of determining the concentration of fibrinogen, fibrinolytic activity, heparin and antifibrinolysin in blood]. Andreenko GV Lab Delo; 1969; 8():477-9. PubMed ID: 4193037 [No Abstract] [Full Text] [Related]
10. Effect of venous occlusion on coagulation and fibrinolytic components in normal subjects. Nilsson IM; Robertson B Thromb Diath Haemorrh; 1968 Dec; 20(3):397-408. PubMed ID: 5710462 [No Abstract] [Full Text] [Related]
11. [Determination of fibrinolytic and antifibrinolytic activity of blood in epidemic Botkin's disease]. Arakelov RA; Abagian IA Zh Eksp Klin Med; 1969; 9(4):61-3. PubMed ID: 5376572 [No Abstract] [Full Text] [Related]
12. [Fibrinolytic hemorrhages in childhood and their therapy with PAMBA]. Hoffmann W; Mey U Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):88-93. PubMed ID: 4173887 [No Abstract] [Full Text] [Related]
13. [Fibrinolytic bleedings in urology]. Lipsky H; Hubmer O Z Urol Nephrol; 1969; 62(6):453-61. PubMed ID: 5314209 [No Abstract] [Full Text] [Related]
14. [Fibrinolytic and antifibrinolytic treatment]. Sterkowicz S Wiad Lek; 1968 Jun; 21(12):1035-41. PubMed ID: 4875370 [No Abstract] [Full Text] [Related]
15. [Increased fibrinolytic activity in thrombocytopenia and its therapeutic modification by PAMBA]. Thiele G Z Arztl Fortbild (Jena); 1969 Dec; 63(24):1296-8. PubMed ID: 5403440 [No Abstract] [Full Text] [Related]
18. [New possibilities for quantitative determination of blood clotting and fibrinolytic factors]. Ivanov V; Shipkov T Vutr Boles; 1982; 21(6):7-13. PubMed ID: 6761966 [No Abstract] [Full Text] [Related]
19. [Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium]. UszyĆski M Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1971; 16():159-90. PubMed ID: 5004447 [No Abstract] [Full Text] [Related]
20. "Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms. Robertson BR; Pandolfi M; Nilsson IM Acta Chir Scand; 1972; 138(5):429-36. PubMed ID: 5055974 [No Abstract] [Full Text] [Related] [Next] [New Search]